The present invention relates generally to a compact, precise, reliable and low cost pump suitable for subcutaneous delivery of a liquid pharmaceutical product. More particularly, embodiments of the present invention relate to a pump with a piston or diaphragm that undergoes a rotational motion. The pharmaceutical product to be delivered may be insulin for diabetic patients.
Diabetes is a group of diseases marked by high levels of blood glucose resulting from defects in insulin production, insulin action, or both. There are 23.6 million people in the United States, or 8% of the population, who have diabetes. The total prevalence of diabetes has increased 13.5% since the 2005-2007 time period. Diabetes can lead to serious complications and premature death, but there are well-known products available for people with diabetes to help control the disease and lower the risk of complications.
Treatment options for people with diabetes include specialized diets, oral medications and/or insulin therapy. The primary goal for diabetes treatment is to control the patient's blood glucose (sugar) level in order to increase the chances of a complication-free life. It is not always easy, however, to achieve good diabetes management, while balancing other life demands and circumstances.
Currently, there are two principal modes of daily insulin therapy for the treatment of type 1 diabetes. The first mode includes syringes and insulin pens that require a needle stick at each injection, typically three to four times per day that are simple to use and relatively low in cost. Another widely adopted and effective method of treatment for managing diabetes is the use of an insulin pump. Insulin pumps can help the user keep blood glucose levels within target ranges based on individual needs, by continuous infusion of insulin. By using an insulin pump, the user can match insulin therapy to lifestyle, rather than matching lifestyle to how an insulin injection is working for the user.
Conventional insulin pumps are capable of delivering rapid or short-acting insulin 24 hours a day through a catheter placed under the skin. Insulin doses are typically administered at a basal rate and in a bolus dose. Basal insulin is delivered continuously over 24 hours, and keeps the user's blood glucose levels in a consistent range between meals and overnight. Some insulin pumps are capable of programming the basal rate of insulin to vary according to the different times of the day and night. Bolus doses are typically administered when the user takes a meal, and generally provide a single additional insulin injection to balance the carbohydrates consumed. Some conventional insulin pumps enable the user to program the volume of the bolus dose in accordance with the size or type of the meal consumed. Conventional insulin pumps also enable a user to take in a correctional or supplemental bolus of insulin to compensate for a low blood glucose level at the time the user is calculating a meal bolus.
There are many advantages of conventional insulin pumps over other methods of diabetes treatment. Insulin pumps deliver insulin over time rather than in single injections and thus typically result in less variation within the blood glucose range that is recommended by the American Diabetes Association. Conventional insulin pumps also reduce the number of needle sticks which the patient must endure, and make diabetes management easier and more effective for the user, thus considerably enhancing the quality of the user's life.
A major disadvantage of existing insulin pumps is that, in spite of their portability, they include multiple components and can be heavy and cumbersome to use. They are also typically more expensive than other methods of treatment. From a lifestyle standpoint, the conventional pump with its associated tubing and infusion set can be inconvenient and bothersome for the user.
Unlike a conventional infusion pump, a patch pump is an integrated device that combines most or all of the fluidic components, including the fluid reservoir, pumping mechanism and a mechanism for automatically inserting the cannula, in a single housing which is adhesively attached to an infusion site on the patient's skin, and does not require the use of a separate infusion or tubing set. Some patch pumps wirelessly communicate with a separate controller (as in one device sold by Insulet Corporation under the brand name OmniPodĀ®), while others are completely self-contained. Such devices are replaced on a frequent basis, such as every three days, when the insulin supply is exhausted.
As a patch pump is designed to be a self-contained unit that is worn by the diabetic patient, it is preferable to be as small as possible so that it does not interfere with the activities of the user. In order to minimize discomfort to the user, it is preferable to minimize the overall dimension of the patch pump. However, in order to minimize the overall dimensions of the patch pump, its constituent parts should be reduced in size as much as possible.
Accordingly, there is a need in the art for a liquid pump that is precise, compact and cost-effective, so that it can be provided as part of a disposable system such as a patch pump.
It is an object of exemplary embodiment of the present invention to provide a precise, compact, cost-effective pump for a wearable medical device, so that more diabetes patients can benefit from the advantages these devices provide.
According to one embodiment of the present invention, there is provided a pump for the pumping of a liquid, said pump comprising an axially translatable chamber with an inlet and an outlet, a piston or a diaphragm rotatably received in the chamber, a first valve between the inlet and the chamber, a second valve between the outlet and the chamber, a cam affixed to the chamber, a follower affixed to the piston and in contact with the cam for axially translating the chamber, and a biasing means acting on the chamber for applying a force on the chamber in an axial direction of the chamber to maintain such contact.
An advantage of a pump according to an embodiment of the present invention is that very small and precise amounts of liquid medicament can be pumped per revolution of the piston or a diaphragm. This enables small liquid dosages to be injected very precisely, and as a result, higher drug concentration in the reservoir becomes possible. Higher drug concentration further reduces the size of the drug reservoir and prolongs the replacement interval between reservoir cartridges. Due to the compact size of a pump according to an embodiment of the present invention, it may be employed in a wearable patch pump or otherwise positioned close to the point of injection.
According to another aspect of the present invention, there is provided a method for operating a pump comprising an axially translatable chamber with an inlet and an outlet, a piston or diaphragm rotatably received in the chamber, a first valve between the inlet and the chamber, and a second valve between the outlet and the chamber, the method comprising the steps of rotating the piston or diaphragm, translating the rotation of the piston or diaphragm into axial reciprocation of the chamber and opening and closing the first and second valves to allow liquid to be drawn into and expelled from the chamber by the piston or diaphragm.
The above and other exemplary objects, features and advantages of the present invention will become more apparent from the following description of certain exemplary embodiments thereof when taken in conjunction with the accompanying drawings, in which:
Throughout the drawings, like reference numerals will be understood to refer to like elements, features and structures.
The matters exemplified in this description are provided to assist in an understanding of exemplary embodiments of the invention, and are made with reference to the accompanying drawings. Descriptions of well-known functions and constructions are omitted for clarity and conciseness.
As shown in
The chamber 104 comprises an inlet 105, an outlet 106, an inlet valve 112 and an outlet valve 111. The valves 111 and 112 may be self-activating check valves, or externally controlled valves that are operated in sequence by a suitable mechanical linkage or electrical control system (not shown). A biasing means 107 such as a coil spring acts on the chamber 104 for applying an upward biasing force on the bottom of the chamber 104 in an axial direction of the chamber 104. The biasing means 107 maintains constant contact between the post 103 and the cam surface 113, causing the chamber 104 to translate up and down along the axial direction of the chamber 104. The rotational motion of the post 103 and the piston 102 is transformed into linear motion of the chamber 104. When the post 103 rotates, it pushes the cam surface 113 of the chamber 104.
The opening and closing of valves 111 and 112 is synchronized with the rotation of the post 103. Both the inlet valve 112 and the outlet valve 111 open and close as a function of the relative displacement between the post 103 and the cam surface 113 to allow liquid to flow in and out of the chamber 104.
The biasing means 107 maintains an appropriate pressure to maintain constant contact between the post 103 and the cam surface 113 throughout the pumping cycle. The pumping process repeats itself to maintain a steady flow of fluid through the chamber 104.
When the post 103 rotates to a certain position, the cam surface 113 and the chamber 104 are pushed downward by the post 103, and the pinch valve 109 is triggered to close the flexible outlet conduit 106. When post rotates to another position, the chamber 104 is pushed upward by the biasing means 107, the pinch valve 108 is triggered to close the flexible inlet conduit 105. The pumping process repeats itself to maintain a steady flow of fluid through the chamber 104.
In
The outlet valve 211 is opened to allow fluid to be pumped out of the chamber 204 when the cam surface 213 is pushed upward by the biasing means 207. The diaphragm is in the flexed-down position as illustrated in
While the present invention has been shown and described with reference to particular illustrative embodiments, it is not to be restricted by the exemplary embodiments but only by the appended claims and their equivalents. It is to be appreciated that those skilled in the art can change or modify the exemplary embodiments without departing from the scope of the present invention. In addition, the features of the various embodiments can be combined with each other to form new embodiments without departing from the scope of the present invention.
Number | Name | Date | Kind |
---|---|---|---|
1866217 | Mayer | Jul 1932 | A |
3914073 | Fusco | Oct 1975 | A |
4067668 | Nimell | Jan 1978 | A |
5385992 | Koskinen et al. | Jan 1995 | A |
5913180 | Ryan | Jun 1999 | A |
6435844 | Fukami | Aug 2002 | B1 |
6461331 | Antwerp | Oct 2002 | B1 |
6740059 | Flaherty | May 2004 | B2 |
7029249 | Bougamont et al. | Apr 2006 | B2 |
7052251 | Nason et al. | May 2006 | B2 |
7104275 | Dille | Sep 2006 | B2 |
7303549 | Flaherty et al. | Dec 2007 | B2 |
7517440 | Anex et al. | Apr 2009 | B2 |
7726955 | Ryser et al. | Jun 2010 | B2 |
7887308 | Navarro | Feb 2011 | B2 |
7976505 | Hines et al. | Jul 2011 | B2 |
8114064 | Alferness et al. | Feb 2012 | B2 |
8162923 | Adams et al. | Apr 2012 | B2 |
8187228 | Bikovsky | May 2012 | B2 |
8202250 | Stutz, Jr. | Jun 2012 | B2 |
8226607 | Carter et al. | Jul 2012 | B2 |
8282366 | Hilber et al. | Oct 2012 | B2 |
8287495 | Michaud et al. | Oct 2012 | B2 |
8298184 | DiPerna et al. | Oct 2012 | B2 |
8353688 | Navarro | Jan 2013 | B2 |
8448824 | DiPerna | May 2013 | B2 |
8469930 | Haueter et al. | Jun 2013 | B2 |
8500700 | Haueter et al. | Aug 2013 | B2 |
8641671 | Michaud et al. | Feb 2014 | B2 |
8957674 | Genoud et al. | Feb 2015 | B2 |
9022755 | Junod et al. | May 2015 | B2 |
9095650 | Matsuura et al. | Aug 2015 | B2 |
9119911 | Haueter et al. | Sep 2015 | B2 |
9222470 | Genoud et al. | Dec 2015 | B2 |
9421327 | Niklaus et al. | Aug 2016 | B2 |
9427517 | Eberhard | Aug 2016 | B2 |
9446193 | Geipel et al. | Sep 2016 | B2 |
9662453 | Teutsch et al. | May 2017 | B2 |
9726172 | Wattellier et al. | Aug 2017 | B2 |
9889253 | Niklaus et al. | Feb 2018 | B2 |
9970436 | Navarro et al. | May 2018 | B2 |
10034977 | Haueter et al. | Jul 2018 | B2 |
11009018 | Wyss | May 2021 | B2 |
20040026461 | Bougamont et al. | Feb 2004 | A1 |
20090112155 | Zhao et al. | Apr 2009 | A1 |
20090123309 | Hilber et al. | May 2009 | A1 |
20090292245 | Basso et al. | Nov 2009 | A1 |
20100057006 | Cassemeyer et al. | Mar 2010 | A1 |
20100065579 | DiPerna | Mar 2010 | A1 |
20100185175 | Kamen et al. | Jul 2010 | A1 |
20110060280 | Caffey et al. | Mar 2011 | A1 |
20110137255 | Nielsen et al. | Jun 2011 | A1 |
20110144586 | Michaud et al. | Jun 2011 | A1 |
20110152824 | DiPerna et al. | Jun 2011 | A1 |
20120126795 | Genoud et al. | May 2012 | A1 |
20120215200 | Matsuura et al. | Aug 2012 | A1 |
20130017099 | Genoud et al. | Jan 2013 | A1 |
20130053816 | DiPerna et al. | Feb 2013 | A1 |
20130089437 | Kennedy | Apr 2013 | A1 |
20130317324 | Yodfat et al. | Nov 2013 | A1 |
20130324928 | Kruse | Dec 2013 | A1 |
20150297825 | Focht et al. | Oct 2015 | A1 |
20160160854 | Dehan et al. | Jun 2016 | A1 |
20160195074 | Beard et al. | Jul 2016 | A1 |
20160195075 | Adams | Jul 2016 | A1 |
20160213851 | Weibel et al. | Jul 2016 | A1 |
20170184091 | Focht et al. | Jun 2017 | A1 |
20190321556 | McKinnon | Oct 2019 | A1 |
Number | Date | Country |
---|---|---|
4209690 | Sep 1993 | DE |
102009026740 | Dec 2010 | DE |
0042900 | Jan 1982 | EP |
S5390005 | Aug 1978 | JP |
S58113586 | Jul 1983 | JP |
S60252173 | Dec 1985 | JP |
H03260377 | Nov 1991 | JP |
2001132621 | May 2001 | JP |
2002202066 | Jul 2002 | JP |
2004263656 | Sep 2004 | JP |
2013005159 | Jan 2013 | WO |
2013046156 | Apr 2013 | WO |
2015157174 | Oct 2015 | WO |
Entry |
---|
EP-0042900-A1 English Translation, (Year: 1982). |
Number | Date | Country | |
---|---|---|---|
20200025184 A1 | Jan 2020 | US |